{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:07:07Z","timestamp":1784358427015,"version":"3.55.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DML"],"published-print":{"date-parts":[[2018,2,8]]},"DOI":"10.2174\/1872312811666171106151730","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T13:04:41Z","timestamp":1518181481000},"source":"Crossref","is-referenced-by-count":1,"title":["Genotoxicity of 4-(piperazin-1-yl)-8-(trifluoromethyl)pyrido[2,3-e][1,2,4] triazolo[4,3-a]pyrazine, a Potent H4 Receptor Antagonist for the Treatment of Allergy: Evidence of Glyoxal Intermediate Involvement"],"prefix":"10.2174","volume":"11","author":[{"given":"Mithat","family":"Gunduz","sequence":"first","affiliation":[{"name":"PK Sciences, Global Biotransformation, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Cirello","sequence":"additional","affiliation":[{"name":"PK Sciences, Global Biotransformation, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Klimko","sequence":"additional","affiliation":[{"name":"PK Sciences, Global Biotransformation, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer  L.","family":"Dumouchel","sequence":"additional","affiliation":[{"name":"PK Sciences, Global Biotransformation, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra A.","family":"Argikar","sequence":"additional","affiliation":[{"name":"PK Sciences, Global Biotransformation, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Drug Metabolism Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/156854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T13:04:48Z","timestamp":1518181488000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/156854\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872312811666171106151730","relation":{},"ISSN":["1872-3128"],"issn-type":[{"value":"1872-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,8]]}}}